General Information of Drug Off-Target (DOT) (ID: OTOG2BXF)

DOT Name Sonic hedgehog protein (SHH)
Synonyms SHH; EC 3.1.-.-; HHG-1; Shh unprocessed N-terminal signaling and C-terminal autoprocessing domains; ShhNC
Gene Name SHH
Related Disease
Holoprosencephaly 3 ( )
Microphthalmia, isolated, with coloboma 5 ( )
Polydactyly of a triphalangeal thumb ( )
Solitary median maxillary central incisor syndrome ( )
Skeletal system disorder ( )
Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome ( )
Holoprosencephaly ( )
Microphthalmia, isolated, with coloboma ( )
Obsolete hypoplastic tibiae-postaxial polydactyly syndrome ( )
Syndactyly type 4 ( )
Triphalangeal thumb-polysyndactyly syndrome ( )
UniProt ID
SHH_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
3HO5; 3M1N; 3MXW; 6DMY; 6E1H; 6N7G; 6N7H; 6N7K; 6OEV; 6PJV; 6RMG; 6RVD; 7E2I; 7MHZ; 7RHQ; 7URF
EC Number
3.1.-.-
Pfam ID
PF01085 ; PF01079
Sequence
MLLLARCLLLVLVSSLLVCSGLACGPGRGFGKRRHPKKLTPLAYKQFIPNVAEKTLGASG
RYEGKISRNSERFKELTPNYNPDIIFKDEENTGADRLMTQRCKDKLNALAISVMNQWPGV
KLRVTEGWDEDGHHSEESLHYEGRAVDITTSDRDRSKYGMLARLAVEAGFDWVYYESKAH
IHCSVKAENSVAAKSGGCFPGSATVHLEQGGTKLVKDLSPGDRVLAADDQGRLLYSDFLT
FLDRDDGAKKVFYVIETREPRERLLLTAAHLLFVAPHNDSATGEPEASSGSGPPSGGALG
PRALFASRVRPGQRVYVVAERDGDRRLLPAAVHSVTLSEEAAGAYAPLTAQGTILINRVL
ASCYAVIEEHSWAHRAFAPFRLAHALLAALAPARTDRGGDSGGGDRGGGGGRVALTAPGA
ADAPGAGATAGIHWYSQLLYQIGTWLLDSEALHPLGMAVKSS
Function
[Sonic hedgehog protein]: The C-terminal part of the sonic hedgehog protein precursor displays an autoproteolysis and a cholesterol transferase activity. Both activities result in the cleavage of the full-length protein into two parts (ShhN and ShhC) followed by the covalent attachment of a cholesterol moiety to the C-terminal of the newly generated ShhN. Both activities occur in the reticulum endoplasmic. Once cleaved, ShhC is degraded in the endoplasmic reticulum; [Sonic hedgehog protein N-product]: The dually lipidated sonic hedgehog protein N-product (ShhNp) is a morphogen which is essential for a variety of patterning events during development. Induces ventral cell fate in the neural tube and somites. Involved in the patterning of the anterior-posterior axis of the developing limb bud. Essential for axon guidance. Binds to the patched (PTCH1) receptor, which functions in association with smoothened (SMO), to activate the transcription of target genes. In the absence of SHH, PTCH1 represses the constitutive signaling activity of SMO.
KEGG Pathway
Hedgehog sig.ling pathway (hsa04340 )
Axon guidance (hsa04360 )
Pathways in cancer (hsa05200 )
Proteoglycans in cancer (hsa05205 )
Basal cell carcinoma (hsa05217 )
Gastric cancer (hsa05226 )
Reactome Pathway
Hedgehog ligand biogenesis (R-HSA-5358346 )
Hh mutants are degraded by ERAD (R-HSA-5362768 )
Release of Hh-Np from the secreting cell (R-HSA-5362798 )
Ligand-receptor interactions (R-HSA-5632681 )
Hedgehog 'on' state (R-HSA-5632684 )
Activation of SMO (R-HSA-5635838 )
HHAT G278V doesn't palmitoylate Hh-Np (R-HSA-5658034 )
Formation of lateral plate mesoderm (R-HSA-9758920 )
Formation of axial mesoderm (R-HSA-9796292 )
Class B/2 (Secretin family receptors) (R-HSA-373080 )

Molecular Interaction Atlas (MIA) of This DOT

11 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Holoprosencephaly 3 DISSDSO9 Definitive Autosomal dominant [1]
Microphthalmia, isolated, with coloboma 5 DISLHJX9 Definitive Autosomal dominant [2]
Polydactyly of a triphalangeal thumb DIS7WCFY Definitive Autosomal dominant [3]
Solitary median maxillary central incisor syndrome DISEWCUH Definitive Autosomal dominant [3]
Skeletal system disorder DIS5PU87 Moderate Autosomal dominant [1]
Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome DISQ9APO Supportive Autosomal dominant [4]
Holoprosencephaly DISR35EC Supportive Autosomal recessive [5]
Microphthalmia, isolated, with coloboma DISLSEUJ Supportive Autosomal dominant [2]
Obsolete hypoplastic tibiae-postaxial polydactyly syndrome DISA748M Supportive Autosomal dominant [6]
Syndactyly type 4 DISMKGLC Supportive Autosomal dominant [7]
Triphalangeal thumb-polysyndactyly syndrome DIS2V1ZD Supportive Autosomal dominant [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the methylation of Sonic hedgehog protein (SHH). [9]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Sonic hedgehog protein (SHH). [22]
------------------------------------------------------------------------------------
16 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of Sonic hedgehog protein (SHH). [10]
Cisplatin DMRHGI9 Approved Cisplatin decreases the expression of Sonic hedgehog protein (SHH). [11]
Quercetin DM3NC4M Approved Quercetin decreases the expression of Sonic hedgehog protein (SHH). [12]
Arsenic trioxide DM61TA4 Approved Arsenic trioxide decreases the activity of Sonic hedgehog protein (SHH). [13]
Progesterone DMUY35B Approved Progesterone decreases the expression of Sonic hedgehog protein (SHH). [14]
Fluorouracil DMUM7HZ Approved Fluorouracil decreases the expression of Sonic hedgehog protein (SHH). [15]
Folic acid DMEMBJC Approved Folic acid decreases the expression of Sonic hedgehog protein (SHH). [16]
Isotretinoin DM4QTBN Approved Isotretinoin increases the expression of Sonic hedgehog protein (SHH). [17]
Gemcitabine DMSE3I7 Approved Gemcitabine decreases the expression of Sonic hedgehog protein (SHH). [18]
Bexarotene DMOBIKY Approved Bexarotene increases the expression of Sonic hedgehog protein (SHH). [17]
Tofacitinib DMBS370 Approved Tofacitinib increases the expression of Sonic hedgehog protein (SHH). [19]
Urethane DM7NSI0 Phase 4 Urethane decreases the expression of Sonic hedgehog protein (SHH). [20]
Resveratrol DM3RWXL Phase 3 Resveratrol decreases the expression of Sonic hedgehog protein (SHH). [21]
Bisphenol A DM2ZLD7 Investigative Bisphenol A increases the expression of Sonic hedgehog protein (SHH). [23]
U0126 DM31OGF Investigative U0126 decreases the expression of Sonic hedgehog protein (SHH). [14]
SAG DMHOG7W Investigative SAG increases the expression of Sonic hedgehog protein (SHH). [24]
------------------------------------------------------------------------------------
⏷ Show the Full List of 16 Drug(s)

References

1 Classification of Genes: Standardized Clinical Validity Assessment of Gene-Disease Associations Aids Diagnostic Exome Analysis and Reclassifications. Hum Mutat. 2017 May;38(5):600-608. doi: 10.1002/humu.23183. Epub 2017 Feb 13.
2 Novel mutation in sonic hedgehog in non-syndromic colobomatous microphthalmia. Am J Med Genet A. 2003 Jan 30;116A(3):215-21. doi: 10.1002/ajmg.a.10884.
3 Flexible and scalable diagnostic filtering of genomic variants using G2P with Ensembl VEP. Nat Commun. 2019 May 30;10(1):2373. doi: 10.1038/s41467-019-10016-3.
4 The disruption of a novel limb cis-regulatory element of SHH is associated with autosomal dominant preaxial polydactyly-hypertrichosis. Eur J Hum Genet. 2016 Jan;24(1):37-43. doi: 10.1038/ejhg.2015.53. Epub 2015 Mar 18.
5 Recent advances in understanding inheritance of holoprosencephaly. Am J Med Genet C Semin Med Genet. 2018 Jun;178(2):258-269. doi: 10.1002/ajmg.c.31619. Epub 2018 May 22.
6 A specific mutation in the distant sonic hedgehog (SHH) cis-regulator (ZRS) causes Werner mesomelic syndrome (WMS) while complete ZRS duplications underlie Haas type polysyndactyly and preaxial polydactyly (PPD) with or without triphalangeal thumb. Hum Mutat. 2010 Jan;31(1):81-9. doi: 10.1002/humu.21142.
7 Clinical Practice Guidelines for Rare Diseases: The Orphanet Database. PLoS One. 2017 Jan 18;12(1):e0170365. doi: 10.1371/journal.pone.0170365. eCollection 2017.
8 A microduplication of the long range SHH limb regulator (ZRS) is associated with triphalangeal thumb-polysyndactyly syndrome. J Med Genet. 2008 Jun;45(6):370-5. doi: 10.1136/jmg.2007.055699. Epub 2008 Jan 4.
9 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
10 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
11 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
12 Quercetin suppresses pancreatic ductal adenocarcinoma progression via inhibition of SHH and TGF-/Smad signaling pathways. Cell Biol Toxicol. 2021 Jun;37(3):479-496. doi: 10.1007/s10565-020-09562-0. Epub 2020 Oct 17.
13 Arsenic trioxide prevents osteosarcoma growth by inhibition of GLI transcription via DNA damage accumulation. PLoS One. 2013 Jul 8;8(7):e69466. doi: 10.1371/journal.pone.0069466. Print 2013.
14 Ovarian steroids, mitogen-activated protein kinases, and/or aspartic proteinases cooperate to control endometrial remodeling by regulating gene expression in the stroma and glands. Endocrinology. 2010 Sep;151(9):4515-26. doi: 10.1210/en.2009-1398. Epub 2010 Jul 21.
15 Down-regulation of Sonic hedgehog signaling pathway activity is involved in 5-fluorouracil-induced apoptosis and motility inhibition in Hep3B cells. Acta Biochim Biophys Sin (Shanghai). 2008 Sep;40(9):819-29.
16 Folic acid supplementation dysregulates gene expression in lymphoblastoid cells--implications in nutrition. Biochem Biophys Res Commun. 2011 Sep 9;412(4):688-92. doi: 10.1016/j.bbrc.2011.08.027. Epub 2011 Aug 16.
17 Pituitary specific retinoid-X receptor ligand interactions with thyroid hormone receptor signaling revealed by high throughput reporter and endogenous gene responses. Toxicol In Vitro. 2015 Oct;29(7):1609-18. doi: 10.1016/j.tiv.2015.06.018. Epub 2015 Jun 19.
18 A fine-needle aspirate-based vulnerability assay identifies polo-like kinase 1 as a mediator of gemcitabine resistance in pancreatic cancer. Mol Cancer Ther. 2010 Feb;9(2):311-8. doi: 10.1158/1535-7163.MCT-09-0693. Epub 2010 Jan 26.
19 White-to-brown metabolic conversion of human adipocytes by JAK inhibition. Nat Cell Biol. 2015 Jan;17(1):57-67. doi: 10.1038/ncb3075. Epub 2014 Dec 8.
20 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
21 Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease. Cardiovasc Drugs Ther. 2013 Feb;27(1):37-48. doi: 10.1007/s10557-012-6427-8.
22 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
23 Bisphenol A stimulates adrenal cortical cell proliferation via ER-mediated activation of the sonic hedgehog signalling pathway. J Steroid Biochem Mol Biol. 2018 Apr;178:254-262. doi: 10.1016/j.jsbmb.2018.01.004. Epub 2018 Jan 4.
24 Differential role of Pax6 and its interaction with Shh-Gli1-IDH2 axis in regulation of glioma growth and chemoresistance. J Biochem Mol Toxicol. 2023 Feb;37(2):e23241. doi: 10.1002/jbt.23241. Epub 2022 Oct 7.